The DOI matches its Crossref record; 364 of the 364 references it cites were found in a registry or an index.
Bone metastasis: mechanisms, therapies, and biomarkers
Open accessAbstract
Skeletal metastases are frequent complications of many cancers, causing bone complications (fractures, bone pain, disability) that negatively affect the patient’s quality of life. Here, we first discuss the burden of skeletal complications in cancer bone metastasis. We then describe the pathophysiology of bone metastasis. Bone metastasis is a multistage process: long before the development of clinically detectable metastases, circulating tumor cells settle and enter a dormant state in normal vascular and endosteal niches present in the bone marrow, which provide immediate attachment and shelter, and only become active years later as they proliferate and alter the functions of bone-resorbing (osteoclasts) and bone-forming (osteoblasts) cells, promoting skeletal destruction. The molecular mechanisms involved in mediating each of these steps are described, and we also explain how tumor cells interact with a myriad of interconnected cell populations in the bone marrow, including a rich vascular network, immune cells, adipocytes, and nerves. We discuss metabolic programs that tumor cells could engage with to specifically grow in bone. We also describe the progress and future directions of existing bone-targeted agents and report emerging therapies that have arisen from recent advances in our understanding of the pathophysiology of bone metastases. Finally, we discuss the value of bone turnover biomarkers in detection and monitoring of progression and therapeutic effects in patients with bone metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–364 of 364
A niche-dependent myeloid transcriptome signature defines dormant myeloma cells
Khoo, W. H., Ledergor, G., Weiner, A., Roden, D. L., Terry, R. L., McDonald, M. M., Chai, R. C. C., Veirman, K. D., Owen, K. L., Opperman, K. S., et al. (2019) · Blood · doi:10.1182/blood.2018880930 · Cited by 140
GAS6 Receptor Status Is Associated with Dormancy and Bone Metastatic Tumor Formation
Taichman, R. S., Patel, L. R., Bedenis, R., Wang, J., Weidner, S., Schumann, T., Yumoto, K., Berry, J. E., Shiozawa, Y., & Pienta, K. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061873 · Cited by 138
Huang, C., Lira, C. B. B., Chu, K., Bilen, M. A., Lee, Y.-C., Ye, X., Kim, S. M., Ortiz, A., Wu, F. L., Logothetis, C. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3016 · Cited by 136
Sterling, J. A. R., Oyajobi, B. O., Grubbs, B. G., Padalecki, S. S., Munoz, S. A., Gupta, A., Story, B. M., Zhao, M., & Mundy, G. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0452 · Cited by 135
Hiraoka, K., Zenmyo, M., Watari, K., Iguchi, H., Fotovati, A., Kimura, Y. N., Hosoi, F., Shoda, T., Nagata, K., Osada, H., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00880.x · Cited by 135
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer
Gawrzak, S., Rinaldi, L., Gregorio, S., Arenas, E. J., Salvador, F., Urosevic, J., Figueras-Puig, C., Rojo, F., Barrantes, I. D. B., Cejalvo, J. M., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-017-0021-z · Cited by 135
Bu, G., Lü, W., Liu, C., Selander, K. S., Yoneda, T., Hall, C. L., Keller, E. T., & Li, Y. (2008) · International Journal of Cancer · doi:10.1002/ijc.23625 · Cited by 132
The role of osteoblasts in bone metastasis
Ottewell, P. D. (2016) · Journal of bone oncology · doi:10.1016/j.jbo.2016.03.007 · Cited by 132
Self-citationLlombart‐Cussac, A., Frassoldati, A., Paija, O., Sleeboom, H. P., Jérusalem, G., Mebis, J., Deleu, I., Miller, J. C., Schenk, N., & Neven, P. (2011) · Clinical Breast Cancer · doi:10.1016/j.clbc.2011.08.002 · Cited by 131
Alam, A. S. M. T., Gallagher, A. C., Shankar, V. S., Ghatei, M. A., Datta, H. K., Huang, C. L.-H., Moonga, B. S., Chambers, T. J., Bloom, S. R., & Zaidi, M. (1992) · Endocrinology · doi:10.1210/endo.130.6.1597159 · Cited by 129
Barrett-Lee, P. J., Casbard, A. C., Abraham, J., Hood, K., Coleman, R. E., Simmonds, P., Timmins, H., Wheatley, D. A., Grieve, R., Griffiths, G. O., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70539-4 · Cited by 128
Self-citationJamieson, W. L., Shimizu, S., D'Ambrosio, J. A., Meucci, O., & Fatatis, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1315 · Cited by 128
Lotinun, S., Pearsall, R. S., Davies, M. V., Marvell, T. H., Monnell, T. E., Ucran, J. A., Fajardo, R. J., Kumar, R., Underwood, K. W., Seehra, J. S., et al. (2010) · Bone · doi:10.1016/j.bone.2010.01.370 · Cited by 127
Thudi, N. K., Martin, C. K., Murahari, S., Shu, S. T., Lanigan, L. G., Werbeck, J. L., Keller, E. T., McCauley, L. K., Pinzone, J. J., & Rosol, T. J. (2010) · The Prostate · doi:10.1002/pros.21277 · Cited by 126
Breast Cancer Cell Colonization of the Human Bone Marrow Adipose Tissue Niche
Templeton, Z. S., Lie, W., Wang, W., Rosenberg‐Hasson, Y., Alluri, R. V., Tamaresis, J. S., Bachmann, M. H., Lee, K., Maloney, W. J., Contag, C. H., et al. (2015) · Neoplasia · doi:10.1016/j.neo.2015.11.005 · Cited by 126
Diedrich, J. D., Rajagurubandara, E. N., Herroon, M. K., Mahapatra, G., Hüttemann, M., & Podgorski, I. (2016) · Oncotarget · doi:10.18632/oncotarget.11712 · Cited by 126
CXCL10 Promotes Osteolytic Bone Metastasis by Enhancing Cancer Outgrowth and Osteoclastogenesis
Lee, J.-H., Kim, H., Kim, K.-O., Jin, W. J., Lee, S., Kim, H.-H., Ha, H., & Lee, Z. H. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0481 · Cited by 125
Wang, N., Docherty, F., Brown, H. K., Reeves, K. J., Fowles, A. C. M., Ottewell, P. D., Dear, T. N., Holen, I., Croucher, P. I., & Eaton, C. L. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2300 · Cited by 124
Self-citationEarly tumor cell dissemination in patients with clinically localized carcinoma of the prostate.
Melchior, S. W., Corey, E., Ellis, W. J., Ross, A. A., Layton, T. J., OSWIN, M. M., Lange, P. H., & Vessella, R. L. (1997) · PubMed · Cited by 124
Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases
Hardaway, A., Herroon, M. K., Rajagurubandara, E. N., & Podgorski, I. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9484-y · Cited by 120
Endocrine aspects of bone metastases
Hofbauer, L. C., Rachner, T. D., Coleman, R. E., & Jakob, F. J. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70203-1 · Cited by 120
Self-citationThe Contribution of the Immune System in Bone Metastasis Pathogenesis
Xiang, L., & Gilkes, D. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040999 · Cited by 120
Bone-Targeted Therapies in Cancer-Induced Bone Disease
Sousa, S., & Clézardin, P. (2017) · Calcified Tissue International · doi:10.1007/s00223-017-0353-5 · Cited by 119
Self-citationZhou, J., Riquelme, M. A., Gao, X., Ellies, L. G., Sun, L., & Jiang, J. X. (2014) · Oncogene · doi:10.1038/onc.2014.113 · Cited by 117
Nelson, J. B., Fizazi, K. S., Miller, K., Higano, C. S., Moul, J. W., Akaza, H., Morris, T., McIntosh, S., Pemberton, K., & Gleave, M. E. (2012) · Cancer · doi:10.1002/cncr.27674 · Cited by 116
Zhu, L., Narloch, J. L., Onkar, S., Joy, M., Broadwater, G., Luedke, C., Hall, A. H. S., Kim, R., Pogue–Geile, K. L., Sammons, S. L., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0755-1 · Cited by 116
Osteoprotegerin in Prostate Cancer Bone Metastasis
Corey, E., Brown, L. G., Kiefer, J., Quinn, J. E., Pitts, T. E. M., Blair, J. M., & Vessella, R. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2033 · Cited by 115
Sclerostin inhibition alleviates breast cancer–induced bone metastases and muscle weakness
Hesse, E., Schröder, S., Brandt, D., Pamperin, J., Saito, H., & Taipaleenmäki, H. (2019) · JCI Insight · doi:10.1172/jci.insight.125543 · Cited by 114
Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis
Pavlović, M., Estape, A. A., Rojo, F., Bellmunt, A., Tarragona, M., Guiu, M., Planet, E., García‐Albéniz, X., Morales, M. L. G., Urosevic, J., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv256 · Cited by 113
Self-citationClinical PET Imaging in Prostate Cancer
Wallitt, K. L., Khan, S. R., Dubash, S., Tam, H., Khan, S., & Barwick, T. D. (2017) · Radiographics · doi:10.1148/rg.2017170035 · Cited by 113
T Regulatory Cells in Bone Remodelling
Bozec, A., & Zaiss, M. M. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0356-1 · Cited by 110
van der Horst, G., van den Hoogen, C., Buijs, J. T., Cheung, H., Bloys, H., Pelger, R. C. M., Lorenzon, G., Heckmann, B., Feyen, J. H. M., Pujuguet, P., et al. (2011) · Neoplasia · doi:10.1593/neo.11122 · Cited by 109
A small molecule antagonist of the α v β3 integrin suppresses MDA-MB-435 skeletal metastasis
Harms, J. F., Welch, D. R., Samant, R. S., Shevde, L. A., Miele, M. E., Babu, G. R., Goldberg, S. F., Gilman, V. R., Sosnowski, D. M., Campo, D. A., et al. (2004) · Clinical & Experimental Metastasis · doi:10.1023/b:clin.0000024763.69809.64 · Cited by 109
Bottos, A., Gotthardt, D., Gill, J. W., Gattelli, A., Frei, A., Tzankov, A., Sexl, V., Wodnar‐Filipowicz, A., & Hynes, N. E. (2016) · Nature Communications · doi:10.1038/ncomms12258 · Cited by 109
The role of biomarkers in the management of bone-homing malignancies
D’Oronzo, S., Brown, J. E., & Coleman, R. E. (2017) · Journal of bone oncology · doi:10.1016/j.jbo.2017.09.001 · Cited by 108
Self-citationRUNX2 promotes breast cancer bone metastasis by increasing integrin α5-mediated colonization
Li, X., Lu, J.-T., Tan, C.-C., Wang, Q.-S., & Feng, Y.-M. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.06.007 · Cited by 107
Myeloid regulatory cells in tumor spreading and metastasis
Keskinov, A. A., & Shurin, M. R. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.07.017 · Cited by 106
Efficacy of an orally active small-molecule inhibitor of RANKL in bone metastasis
Nakai, Y., Okamoto, K., Terashima, A., Ehata, S., Nishida, J., Imamura, T., Ono, T., & Takayanagi, H. (2019) · Bone Research · doi:10.1038/s41413-018-0036-5 · Cited by 106
Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors
Goto, T., Nakao, K., Gunjigake, K. K., Kido, M. A., Kobayashi, S., & Tanaka, T. (2007) · Neuropeptides · doi:10.1016/j.npep.2006.11.002 · Cited by 105
Schoemaker, M. J., Jones, M. E., Wright, L. B., Griffin, J. M., McFadden, E. C., Ashworth, A., & Swerdlow, A. J. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0733-1 · Cited by 104
Coleman, R. E., Collinson, M., Gregory, W. M., et al. (2018) · Journal of bone oncology · doi:10.1016/j.jbo.2018.09.008 · Cited by 104
Self-citationConsensus on the utility of bone markers in the malignant bone disease setting
Coleman, R. E., Costa, L., Fred Saad, C., Cook, R. J., Hadji, P., Terpos, E., Garnero, P., Brown, J. E., Body, J., Smith, M. R., et al. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.02.005 · Cited by 103
Self-citationPantano, F., Croset, M., Driouch, K., Bednarz‐Knoll, N., Iuliani, M., Ribelli, G., Bonnelye, E., Wikman, H., Geraci, S., Bonin, F., et al. (2021) · Oncogene · doi:10.1038/s41388-020-01603-6 · Cited by 103
Self-citationIntegrin alpha2beta1 (α2β1) promotes prostate cancer skeletal metastasis
Sottnik, J. L., Daignault‐Newton, S., Zhang, X., Morrissey, C. M., Hussain, M., Keller, E. T., & Hall, C. L. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9561-6 · Cited by 102
Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity
Kitagawa, Y., Dai, J., Zhang, J., Keller, J. M., Nor, J., Yao, Z., & Keller, E. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1809 · Cited by 101
The role of TGF-β in bone metastasis: novel therapeutic perspectives
Buijs, J. T., Stayrook, K. R., & Guise, T. A. (2012) · BoneKEy Reports · doi:10.1038/bonekey.2012.96 · Cited by 101
Denosumab in patients with cancer—a surgical strike against the osteoclast
Brown, J. E., & Coleman, R. E. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.197 · Cited by 101
Self-citationEffect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2
Gnant, M., Baselga, J. M., Rugo, H. S., Noguchi, S., Burris, H. A., Piccart, M. J., Hortobágyi, G. N., Eakle, J. F., Mukai, H., Iwata, H., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt026 · Cited by 100
Osteocytic connexin hemichannels suppress breast cancer growth and bone metastasis
Zhou, J., Riquelme, M. A., Gu, S., Kar, R., Gao, X., Sun, L., & Jiang, J. X. (2016) · Oncogene · doi:10.1038/onc.2016.101 · Cited by 100
Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer
Lin, S.-C., Lee, Y.-C., Yu, G., Cheng, C., Zhou, X., Chu, K., Murshed, M., Baseler, L. J., Baseler, L., Abe, J., et al. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.05.005 · Cited by 100
Metastatic bone disease: Role of transcription factors and future targets
Pratap, J., Lian, J. B., & Stein, G. S. (2010) · Bone · doi:10.1016/j.bone.2010.05.035 · Cited by 99
Singh, S., Singh, R., Sharma, P., Singh, U. P., Rai, S. N., Chung, L. W. K., Cooper, C. R., Novakovic, K. R., Grizzle, W. E., & Lillard, J. W. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.03.022 · Cited by 99
Bone-Derived IGF Mediates Crosstalk between Bone and Breast Cancer Cells in Bony Metastases
Hiraga, T., Myoui, A., Hashimoto, N., Sasaki, A., Hata, K., Morita, Y., Yoshikawa, H., Rosen, C. J., Mundy, G. R., & Yoneda, T. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3061 · Cited by 98
Lung adenocarcinoma cell-derived exosomal miR-21 facilitates osteoclastogenesis
Xu, Z., Liu, X., Wang, H., Li, J., Dai, L., Li, J., & Dong, C. (2018) · Gene · doi:10.1016/j.gene.2018.05.008 · Cited by 98
Cabozantinib Inhibits Prostate Cancer Growth and Prevents Tumor-Induced Bone Lesions
Dai, J., Zhang, H., Karatsinides, A., Keller, J. M., Kozloff, K. M., Aftab, D. T., Schimmöller, F., & Keller, E. T. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0839 · Cited by 95
RANKL and RANK: From Mammalian Physiology to Cancer Treatment
Rao, S., Cronin, S. J. F., Sigl, V., & Penninger, J. M. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.11.001 · Cited by 95
Devignes, C.-S., Aslan, Y., Brenot, A., Devillers, A., Schepers, K., Fabre, S., Chou, J., Casbon, A.-J., Werb, Z., & Provot, S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718009115 · Cited by 95
68Ga-BBN-RGD PET/CT for GRPR and Integrin αvβ3 Imaging in Patients with Breast Cancer
Zhang, J., Mao, F., Niu, G., Peng, L., Lang, L., Li, F., Ying, H., Wu, H., Pan, B., Zhu, Z., et al. (2018) · Theranostics · doi:10.7150/thno.22601 · Cited by 95
Inhibition of Breast Cancer Metastases by a Novel Inhibitor of TGFβ Receptor 1
Fang, Y., Chen, Y., Yu, L., Zheng, C., Ya, Q., Li, Z., Yang, Z., Zhang, Y., Shi, T., Luo, J., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs485 · Cited by 92
CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment
Westbrook, J. A., Cairns, D. A., Peng, J., Speirs, V., Hanby, A. M., Holen, I., Wood, S. L., Ottewell, P. D., Marshall, H. C., Banks, R. E., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv360 · Cited by 92
Self-citationJamieson, W. L., Zhang, Y., Fong, A. M., Meucci, O., & Fatatis, A. (2011) · Breast Cancer Research · doi:10.1186/bcr3016 · Cited by 91
Duong, L. T., Wesolowski, G. A., Leung, P., Oballa, R. M., & Pickarski, M. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0253 · Cited by 88
Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone
Ottewell, P. D., Wang, N., Meek, J., Fowles, C. A., Croucher, P. I., Eaton, C. L., & Holen, I. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0199 · Cited by 88
Self-citationFradet, A., Sorel, H., Bouazza, L., Goehrig, D., Dépalle, B., Bellahcène, A., Castronovo, V., Follet, H., Descôtes, F., Aubin, J. E., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1431 · Cited by 87
Self-citationTaipaleenmäki, H., Farina, N. H., van Wijnen, A. J., Stein, J. L., Hesse, E., Stein, G. S., & Lian, J. B. (2016) · Oncotarget · doi:10.18632/oncotarget.12593 · Cited by 87
Sympathetic Signaling Reactivates Quiescent Disseminated Prostate Cancer Cells in the Bone Marrow
Decker, A. M., Jung, Y., Cackowski, F. C., Yumoto, K., Wang, J., & Taichman, R. S. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0132 · Cited by 86
FGF‐8 is involved in bone metastasis of prostate cancer
Valta, M. P., Tuomela, J. M., Bjartell, A. S., Valve, E. M., Väänänen, H. K., & Härkönen, P. L. (2008) · International Journal of Cancer · doi:10.1002/ijc.23422 · Cited by 85
Lysyl Oxidase Is a Strong Determinant of Tumor Cell Colonization in Bone
Reynaud, C., Ferreras, L., Mauro, P. D., Kan, C. W. S., Croset, M., Bonnelye, E., Pez, F., Thomas, C., Aimond, G., Karnoub, A. E., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2621 · Cited by 85
Self-citationCapulli, M., Hristova, D., Valbret, Z., Carys, K., Arjan, R., Maurizi, A., Masedu, F., Cappariello, A., Rucci, N., & Teti, A. M. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0501-y · Cited by 85
Efficacy and safety of tanezumab in the treatment of pain from bone metastases
Sopata, M., Katz, N. P., Carey, W., Smith, M. D., Keller, D., Verburg, K. M., West, C. R., Wolfram, G., & Brown, M. (2015) · Pain · doi:10.1097/j.pain.0000000000000211 · Cited by 83
CD8+ T Cells Regulate Bone Tumor Burden Independent of Osteoclast Resorption
Zhang, K., Kim, S., Cremasco, V., Hirbe, A. C., Novack, D. V., Weilbaecher, K. N., & Faccio, R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3922 · Cited by 82
Mulcrone, P. L., Campbell, J. P., Clément-Demange, L., Anbinder, A. L., Merkel, A. R., Brekken, R. A., Sterling, J. A. R., & Elefteriou, F. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3133 · Cited by 80
Lemma, S., Pompo, G. D., Porporato, P. E., Sboarina, M., Russell, S., Gillies, R. J., Baldini, N., Sonveaux, P., & Avnet, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.030 · Cited by 80
TWIST1 Expression in Breast Cancer Cells Facilitates Bone Metastasis Formation
Croset, M., Goehrig, D., Frackowiak, A., Bonnelye, E., Ansieau, S., Puisieux, A., & Clézardin, P. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2215 · Cited by 78
Self-citationMer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy
Cackowski, F. C., Eber, M. R., Rhee, J., Decker, A. M., Yumoto, K., Berry, J. E., Lee, E., Shiozawa, Y., Jung, Y., Aguirre‐Ghiso, J. A., et al. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25768 · Cited by 78
Bone morphogenetic protein‐2 enhances Wnt/β‐catenin signaling‐induced osteoprotegerin expression
Sato, M. M., Nakashima, A., Nashimoto, M., Yawaka, Y., & Tamura, M. (2009) · Genes to Cells · doi:10.1111/j.1365-2443.2008.01258.x · Cited by 76
Identification of NOG as a Specific Breast Cancer Bone Metastasis-supporting Gene
Tarragona, M., Pavlović, M., Estape, A. A., Urosevic, J., Morales, M. L. G., Guiu, M., Planet, E., González‐Suárez, E., & Gomis, R. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.355834 · Cited by 75
Jung, K., & Lein, M. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.09.001 · Cited by 75
Vives, V., Crès, G., Richard, C., Busson, M., Ferrandez, Y., Planson, A., Zeghouf, M., Cherfils, J., Malaval, L., & Blangy, A. (2015) · Nature Communications · doi:10.1038/ncomms7218 · Cited by 74
Furlan, F., Galbiati, C., Jørgensen, N. R., Jensen, J. B., Mrak, E., Rubinacci, A., Talotta, F., Verde, P., & Blasi, F. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070516 · Cited by 74
Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2–WNT Signaling Axis
Nandana, S., Tripathi, M., Duan, P., Chu, C.-Y., Mishra, R., Liu, C., Jin, R., Yamashita, H., Zayzafoon, M., Bhowmick, N. A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-0497 · Cited by 73
Higano, C. S. (2004) · Urologic Clinics of North America · doi:10.1016/j.ucl.2004.01.001 · Cited by 72
Tenascin-C and Integrin α9 Mediate Interactions of Prostate Cancer with the Bone Microenvironment
Martin, R. S., Pathak, R. R., Jain, A., Jung, S. Y., Hilsenbeck, S. G., Piña-Barba, M. C., Sikora, A. G., Pienta, K. J., & Rowley, D. R. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0064 · Cited by 72
Hortobágyi, G. N. (2015) · Neoplasia · doi:10.1016/j.neo.2015.01.005 · Cited by 69
Dolloff, N. G., Shulby, S. S., Nelson, A., Stearns, M. E., Johannes, G. J., Thomas, J. D., Meucci, O., & Fatatis, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208815 · Cited by 69
Role of WNT7B-induced Noncanonical Pathway in Advanced Prostate Cancer
Zheng, D., Decker, K. F., Zhou, T., Chen, J., Qi, Z., Jacobs, K., Weilbaecher, K. N., Corey, E., Long, F., & Li, J. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0520 · Cited by 69
Coleman, R. E., Hall, A., Albanell, J., Hanby, A. M., Bell, R. H., Cameron, D., Dodwell, D. J., Marshall, H. C., Jean-Mairet, J., Tercero, J.-C., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30603-4 · Cited by 69
Self-citationRON kinase: A target for treatment of cancer-induced bone destruction and osteoporosis
Andrade, K., Fornetti, J., Zhao, L., Miller, S. C., Randall, R. L., Anderson, N., Waltz, S. E., McHale, M., & Welm, A. L. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai9338 · Cited by 68
Falk, S., Bannister, K., & Dickenson, A. H. (2014) · British Journal of Pain · doi:10.1177/2049463714545136 · Cited by 67
Wakabayashi, H., Wakisaka, S., Hiraga, T., Hata, K., Nishimura, R., Tominaga, M., & Yoneda, T. (2017) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-017-0842-7 · Cited by 67
The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer
Sahay, D., Leblanc, R., Grünewald, T. G. P., Ambatipudi, S., Ribeiro, J., Clézardin, P., & Peyruchaud, O. (2015) · Oncotarget · doi:10.18632/oncotarget.3774 · Cited by 66
Self-citationMicroRNAs in the control of metastatic bone disease
Browne, G., Taipaleenmäki, H., Stein, G. S., Stein, J. L., & Lian, J. B. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.03.014 · Cited by 66
Li, Z. G., Yang, J., Vazquez, E. S., Rose, D., Vakar‐Lopez, F., Mathew, P. F., López, A., Logothetis, C. J., Lin, S.-H., & Navone, N. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210694 · Cited by 65
FOXF2 reprograms breast cancer cells into bone metastasis seeds
Wang, S., Li, G.-X., Tan, C.-C., He, R., Kang, L.-J., Lu, J., Li, X., Wang, Q., Liu, P., Zhai, Q.-L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10379-7 · Cited by 65
OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone
Ottewell, P. D., Wang, N., Brown, H. K., Fowles, C. A., Croucher, P. I., Eaton, C. L., & Holen, I. (2015) · International Journal of Cancer · doi:10.1002/ijc.29439 · Cited by 64
Self-citationInhibition of BET proteins and epigenetic signaling as a potential treatment for osteoporosis
Baud’huin, M., Lamoureux, F., Jacques, C., Calleja, L. R., Quillard, T., Charrier, C., Amiaud, J., Berreur, M., Royer, B. B.-L., Owen, R., et al. (2016) · Bone · doi:10.1016/j.bone.2016.09.020 · Cited by 64
Lee, C., Whang, Y. M., Campbell, P. J., Mulcrone, P. L., Elefteriou, F., Cho, S. W., & Park, S. I. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.11.016 · Cited by 63
Fend, L., Accart, N., Kintz, J., Cochin, S., Reymann, C., Pogam, F. L., Marchand, J.-B., Menguy, T., Slos, P., Rooke, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073310 · Cited by 62
Biochemical markers in oncology. Part I: Molecular basis. Part II: Clinical uses
Voorzanger‐Rousselot, N., & Garnero, P. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.01.008 · Cited by 60
RANK expression on breast cancer cells promotes skeletal metastasis
Blake, M., Tometsko, M. E., Miller, R. E., Jones, J. C., & Dougall, W. C. (2013) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9624-3 · Cited by 60
Werner‐Klein, M., Grujovic, A., Irlbeck, C., Obradović, M. M. S., Hoffmann, M., Koerkel-Qu, H., Lu, X., Treitschke, S., Köstler, C., Botteron, C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18701-4 · Cited by 60
Secondini, C., Wetterwald, A., Schwaninger, R., Thalmann, G. N., & Cecchini, M. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016078 · Cited by 59
McCaffrey, G., Thompson, M. L., Majuta, L. A., Fealk, M. N., Chartier, S. R., Longo, G., & Mantyh, P. W. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1220 · Cited by 58
Ouellet, V., Tiedemann, K., Mourskaia, A., Fong, J. E., Tran‐Thanh, D., Amir, E., Clemons, M. J., Perbal, B., Komarova, S. V., & Siegel, P. M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.033 · Cited by 58
The Emerging Role of Osteocytes in Cancer in Bone
Atkinson, E. G., & Delgado‐Calle, J. (2019) · JBMR Plus · doi:10.1002/jbm4.10186 · Cited by 58
Herroon, M. K., Diedrich, J. D., Rajagurubandara, E. N., Martin, C. E., Maddipati, K. R., Kim, S., Heath, E. I., Granneman, J. G., & Podgorski, I. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0540 · Cited by 58
Bone Metastasis: Current State of Play
Turpin, A., Duterque‐Coquillaud, M., & Vieillard, M.-H. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.10.012 · Cited by 58
Park, S. I., Lee, C., Sadler, W. D., Koh, A. J., Jones, J., Seo, J. W., Soki, F. N., Cho, S. W., Daignault, S. D., & McCauley, L. K. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4692 · Cited by 57
Lara, P. N., Ely, B., Quinn, D. I., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju013 · Cited by 57
Chen, G., Luo, Y., Eriksson, D., Meng, X., Cheng, Q., Bäuerle, T., Chen, X., Schett, G. A., & Bözec, A. (2016) · Oncotarget · doi:10.18632/oncotarget.8474 · Cited by 56
Sclerostin induced tumor growth, bone metastasis and osteolysis in breast cancer
Zhu, M., Liu, C., Li, S., Zhang, S., Yao, Q., & Song, Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-11913-7 · Cited by 56
LOX Fails to Substitute for RANKL in Osteoclastogenesis
Tsukasaki, M., Hamada, K., Okamoto, K., Nagashima, K., Terashima, A., Komatsu, N., Win, S. J., Okamura, T., Nitta, T., Yasuda, H., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2990 · Cited by 55
Iuliani, M., Pantano, F., Buttigliero, C., Fioramonti, M., Bertaglia, V., Vincenzi, B., Zoccoli, A., Ribelli, G., Tucci, M., Vignani, F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3724 · Cited by 53
Bisphosphonates in preclinical bone oncology
Clézardin, P., Benzaïd, I., & Croucher, P. I. (2010) · Bone · doi:10.1016/j.bone.2010.11.017 · Cited by 52
Self-citationTreatment of Metastatic Bone Disease and the Emerging Role of Radium-223
Coleman, R. E. (2016) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2015.10.012 · Cited by 51
Self-citationTumor-expressed adrenomedullin accelerates breast cancer bone metastasis
Siclari, V. A., Mohammad, K. S., Tompkins, D. R., Davis, H., McKenna, C. R., Peng, X., Wessner, L. L., Niewolna, M., Guise, T. A., Suvannasankha, A., et al. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0458-y · Cited by 50
Kimura, T., Kuwata, T., Ashimine, S., Yamazaki, M., Yamauchi, C., Nagai, K., Ikehara, A., Feng, Y., Dimitrov, D. S., Saito, S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0982 · Cited by 50
Liu, Z., Liu, H., He, J., Lin, P., Tong, Q., & Yang, J. (2020) · Science Signaling · doi:10.1126/scisignal.aay8203 · Cited by 49
Hypoxia induces RANK and RANKL expression by activating HIF-1α in breast cancer cells
Tang, Z.-N., Zhang, F., Tang, P., Qi, X., & Jiang, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.035 · Cited by 49
Westbrook, J. A., Wood, S. L., Cairns, D. A., McMahon, K., Gahlaut, R., Thygesen, H., Shires, M., Roberts, S., Marshall, H., Oliva, M. R., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5197 · Cited by 47
Self-citationLipton, A., Smith, M. R., Fizazi, K. S., Stopeck, A., Henry, D. H., Brown, J. E., Shore, N. D., Fred Saad, C., Spencer, A. G., Zhu, L., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-3086 · Cited by 47
Brown, J. E., Rathbone, E. J., Hinsley, S., Gregory, W. M., Gossiel, F., Marshall, H. C., Burkinshaw, R., Shulver, H., Thandar, H., Bertelli, G., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx280 · Cited by 47
Self-citationWu, A., He, Y., Broomfield, A., Paatan, N. J., Harrington, B. S., Tseng, H., Beaven, E. A., Kiernan, D., Swindle, P., Clubb, A., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4718 · Cited by 46
Annexin 2–CXCL12 Interactions Regulate Metastatic Cell Targeting and Growth in the Bone Marrow
Jung, Y., Wang, J., Lee, E., McGee, S., Berry, J. E., Yumoto, K., Dai, J., Keller, E. T., Shiozawa, Y., & Taichman, R. S. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0118 · Cited by 44
Human ex vivo 3D bone model recapitulates osteocyte response to metastatic prostate cancer
Choudhary, S., Ramasundaram, P., Dziopa, E., Mannion, C. M., Kissin, Y., Tricoli, L., Albanese, C., Lee, W., & Zilberberg, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-36424-x · Cited by 44
Hall, C. L., Zhang, H., Baile, S., Ljungman, M. E., Kuhstoss, S. A., & Keller, E. T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0440 · Cited by 43
Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells
Ubellacker, J. M., Haider, M., DeCristo, M. J., Allocca, G., Brown, N. J., Silver, D. P., Holen, I., & McAllister, S. S. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0815-8 · Cited by 43
Self-citationThe role of Runx2 in facilitating autophagy in metastatic breast cancer cells
Tandon, M., Othman, A. H., Ashok, V., Stein, G. S., & Pratap, J. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25916 · Cited by 42
Herroon, M. K., Rajagurubandara, E. N., Diedrich, J. D., Heath, E. I., & Podgorski, I. (2018) · Scientific Reports · doi:10.1038/s41598-017-17800-5 · Cited by 42
Polymorphonuclear MDSCs are enriched in the stroma and expanded in metastases of prostate cancer
Wen, J., Huang, G., Liu, S., Wan, J., Wang, X., Zhu, Y., Kaliney, W. J., Zhang, C., Liang Cheng, C., Wen, X., et al. (2020) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.160 · Cited by 42
Vargas, G., Bouchet, M., Bouazza, L., Reboul, P., Boyault, C., Gervais, M., Kan, C. W. S., Benetollo, C., Brevet, M., Croset, M., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0579-3 · Cited by 41
Self-citationIntegrins in Bone Metastasis Formation and Potential Therapeutic Implications
Clézardin, P. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909789760348 · Cited by 39
Self-citationCha, Y. J., Jung, W. H., & Koo, J. S. (2017) · Disease Markers · doi:10.1155/2017/7062517 · Cited by 38
Reyes, M. E., Fujii, T., Branstetter, D. G., Krishnamurthy, S., Masuda, H., Wang, X., Reuben, J. M., Woodward, W. A., Edwards, B. J.-A., Hortobágyi, G. N., et al. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4233-5 · Cited by 38
Lee, R. J., & Smith, M. R. (2013) · The Cancer Journal · doi:10.1097/ppo.0b013e318281e280 · Cited by 37
Immune regulation of bone metastasis
Capietto, A.-H., & Faccio, R. (2014) · BoneKEy Reports · doi:10.1038/bonekey.2014.95 · Cited by 37
Romosozumab Treatment in Postmenopausal Osteoporosis
Cosman, F., Crittenden, D. B., & Grauer, A. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1615367 · Cited by 37
Zhang, J., Pang, Y.-X., Xie, T., & Zhu, L. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s200643 · Cited by 37
A Subpopulation of Stromal Cells Controls Cancer Cell Homing to the Bone Marrow
Rossnagl, S., Ghura, H., Groth, C., Altrock, E., Jakob, F. J., Schott, S., Wimberger, P., Link, T., Kuhlmann, J. D., Stenzl, A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3507 · Cited by 36
Bone metastases from lung cancer: A paradigm for multidisciplinary onco-rheumatology management
Confavreux, C. B., Pialat, J., Belliere, A., Brevet, M., Decroisette, C., Tescaru, A., Wegrzyn, J., Barrey, C. Y., Mornex, F., Souquet, P.-J., et al. (2018) · Joint Bone Spine · doi:10.1016/j.jbspin.2018.03.005 · Cited by 36
Self-citationProstate-Specific Antigen Induces Osteoplastic Changes by an Autonomous Mechanism
Yonou, H., Aoyagi, Y., Kanomata, N., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6129 · Cited by 35
Hypoxia induces PTHrP gene transcription in human cancer cells through the HIF-2α
Manisterski, M., Golan, M., Amir, S., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.18.12931 · Cited by 35
Targeting bone metastatic cancer: Role of the mTOR pathway
Bertoldo, F., Silvestris, F., Ibrahim, T., Cognetti, F., Generali, D., Ripamonti, C. I., Amadori, D., Colleoni, M. A., Conte, P., Mastro, L. D., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.01.009 · Cited by 35
Modulating Bone Marrow Hematopoietic Lineage Potential to Prevent Bone Metastasis in Breast Cancer
Ubellacker, J. M., Baryawno, N., Sévère, N., DeCristo, M. J., Sceneay, J., Hutchinson, J. N., Haider, M., Rhee, C., Qin, Y., Gregory, W. M., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0548 · Cited by 34
Self-citationAdipogenic niches for melanoma cell colonization and growth in bone marrow
Wang, J., Chen, G., Cao, S., Zhao, M.-C., Liu, Y., Chen, X., & Qian, C. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.14 · Cited by 32
Pantano, F., Rossi, E. M. C., Iuliani, M., Facchinetti, A., Simonetti, S., Ribelli, G., Zoccoli, A., Vincenzi, B., Tonini, G., Zamarchi, R., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58339-2 · Cited by 32
Fradet, A., Bouchet, M., Delliaux, C., Gervais, M., Kan, C. W. S., Benetollo, C., Pantano, F., Vargas, G., Bouazza, L., Croset, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12787 · Cited by 30
Self-citationOwen, K. L., & Parker, B. S. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.11.023 · Cited by 30
ERRα Expression in Bone Metastases Leads to an Exacerbated Antitumor Immune Response
Bouchet, M., Lainé, A., Boyault, C., Proponnet-Guérault, M., Meugnier, E., Bouazza, L., Kan, C. W. S., Geraci, S., Moghrabi, S. E., Hernández‐Vargas, H., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3584 · Cited by 30
Self-citationLarson, S. R., Chin, J., Zhang, X., Brown, L. G., Coleman, I. M., Lakely, B., Tenniswood, M., Corey, E., Nelson, P. S., Vessella, R. L., et al. (2013) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9625-2 · Cited by 29
Boudot, C., Hénaut, L., Thiem, U., Geraci, S., Galante, M., Saldanha, P., Saidak, Z., Six, I., Clézardin, P., Kamel, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16999 · Cited by 29
Self-citationClément-Demange, L., Mulcrone, P. L., Tabarestani, T. Q., Sterling, J. A. R., & Elefteriou, F. (2018) · Journal of bone oncology · doi:10.1016/j.jbo.2018.09.002 · Cited by 28
Leto, G. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22272 · Cited by 26
Watanabe, K., Hirata, M., Tominari, T., Matsumoto, C., Fujita, H., Yonekura, K., Murphy, G., Nagase, H., Miyaura, C., & Inada, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.727875 · Cited by 26
Concurrent antitumor and bone-protective effects of everolimus in osteotropic breast cancer
Browne, A. J., Kubasch, M. L., Göbel, A., Hadji, P., Chen, D. J., Rauner, M., Stölzel, F., Hofbauer, L. C., & Rachner, T. D. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0885-7 · Cited by 26
Yonou, H., Horiguchi, Y., Ohno, Y., Namiki, K., Yoshioka, K., Ohori, M., Hatano, T., & Tachibana, M. (2007) · The Prostate · doi:10.1002/pros.20574 · Cited by 24
Vidula, N., Yau, C. S. F., Li, J., Esserman, L. J., & Rugo, H. S. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4318-1 · Cited by 23
Maeda, H., Yonou, H., Yano, K., Ishii, G., Saito, S., & Ochiai, A. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.096 · Cited by 22
Matricellular proteins as regulators of cancer metastasis to bone
Trotter, T. N., & Yang, Y. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.01.006 · Cited by 22
Intracranial meningioma with carcinoma tumor-to-tumor metastasis: two case reports
Pham, J. T., Kim, R. C., Nguyen, A., Bota, D. A., Kong, X., Vadera, S., Hsu, F. P. K., & Carrillo, J. (2018) · CNS Oncology · doi:10.2217/cns-2017-0022 · Cited by 22
Development of a realistic in vivo bone metastasis model of human renal cell carcinoma
Valta, M. P., Zhao, H., Ingels, A., Thong, A. E. C., Nolley, R., Saar, M., & Peehl, D. M. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9651-8 · Cited by 20
Megakaryocytes in Bone Metastasis: Protection or Progression?
Maroni, P. (2019) · Cells · doi:10.3390/cells8020134 · Cited by 19
Racaru, L. V., Sinigaglia, M., Kanoun, S., Bouallègue, F. B., Tal, I., Brillouet, S., Bauriaud, M., Zerdoud, S., Dierickx, L., Vallot, D., et al. (2018) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000850 · Cited by 15
Zang, L., Ma, M., Hu, J., Qiu, H., Huang, B. S., & Chu, T. (2015) · Scientific Reports · doi:10.1038/srep18324 · Cited by 12
Cited by
Hallmarks of peripheral nerve function in bone regeneration
Tao, R., Mi, B., Hu, Y., Lin, S., Xiong, Y., Lu, X., Panayi, A. C., Li, G., & Liu, G. (2023) · Bone Research · doi:10.1038/s41413-022-00240-x · Cited by 110
Zhang, Y., Wang, Y., Zhu, A., Yu, N., Xia, J., & Li, J. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202310252 · Cited by 43
Metadata
- Authors
- Clézardin, P., Coleman, R., Puppo, M., Ottewell, P., Bonnelye, E., Paycha, F., Confavreux, C. B., & Holen, I.
- Venue
- Physiological Reviews
- Publisher
- American Physiological Society
- Published
- 2021-07-01
- Volume
- 101
- Issue
- 3
- Pages
- 797-855
- ISSN
- 0031-9333 (ISSN-L)
- 1522-1210
- OpenAlex
- W3116510596
- Cited by
- 416
- References
- 364
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.